Cognex Corporation (cgnx)
CGNX — Company Overview
Cognex Corporation (CGNX) is a mid-cap company in the Technology sector, operating in Scientific & Technical Instruments.
| Ticker | CGNX |
| Sector | Technology |
| Industry | Scientific & Technical Instruments |
| Exchange | NMS |
| Market cap | $9.79B |
| Last price | $58.19 |
| Size category | Mid Cap |
CGNX — Business Description
Cognex Corporation (CGNX) operates in Scientific & Technical Instruments within the broader Technology market. Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks in the United States, Europe, Greater China, and internationally. Its machine vision products are used to automate the manufacture and distribution of discrete items, such as mobile phones, automotive components, and e-commerce packages, by locating, identifying, inspecting, and measuring them. The company offers VisionPro software, a suite of patented vision tools for traditional rule-based tools and deep learning-enabled tools for advanced programming; vision systems that combine smart cameras and software to perform a wide range of tasks, including part location, i…
Official website: https://www.cognex.com.
CGNX — Investment Thesis
The investment thesis for Cognex Corporation (CGNX) rests on how Technology dynamics, profitability, and valuation interact at today's price.
- Revenue is expanding at roughly 16.9% year-over-year (public data).
- Trailing P/E of 55.95× implies elevated growth expectations at the current price.
- Forward P/E (28.75×) is below trailing P/E — earnings may be expected to improve.
- Dividend yield near 0.6% adds an income component to total return.
- Equity market capitalization is approximately $9.79B.
See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.
CGNX — Financial Health
Financial health for Cognex Corporation (CGNX) is summarized from publicly reported profitability, leverage, and cash-flow metrics.
Profit margin of 16.1% indicates solid bottom-line conversion. Positive free cash flow of $195.67M supports balance-sheet flexibility.
| Trailing P/E | 55.95× |
| Forward P/E | 28.75× |
| Price / Sales | 8.99× |
| Price / Book | 6.01× |
| Gross margin | 68.9% |
| Operating margin | 29.4% |
| Profit margin | 16.1% |
| Return on equity | 11.1% |
| Debt / Equity | 4.45 |
| Free cash flow | $195.67M |
CGNX — Growth Outlook
Growth outlook for Cognex Corporation (CGNX) depends on demand trends in Scientific & Technical Instruments and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 16.9% indicates strong top-line momentum.
- Earnings growth of 79.2% year-over-year supports improving profitability.
- Price is 20.2% below the 52-week high.
CGNX — Competitive Position
Cognex Corporation (CGNX) is evaluated against peers on scale, margin structure, and capital efficiency within Technology.
- Competes within Technology, specifically in Scientific & Technical Instruments.
- Market capitalization of $9.79B places CGNX among mid-cap peers.
- Gross margin near 68.9% may reflect pricing power or favorable mix.
CGNX — Strengths
Strengths for Cognex Corporation (CGNX) inferred from public financial metrics:
- Revenue growth of 16.9% year-over-year.
- Earnings growth of 79.2% year-over-year.
- Gross margin of 68.9% supports competitive unit economics.
- Positive free cash flow ($195.67M).
- Moderate leverage (debt/equity 4.45).
CGNX — Weaknesses
Weaknesses and pressure points for Cognex Corporation (CGNX) based on available data:
- Elevated trailing P/E (55.95×) limits valuation margin of safety.
- High beta (1.49) amplifies market swings.
CGNX — Opportunities
- Sustained revenue growth (16.9%) could support multiple expansion if margins hold.
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
- Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.
CGNX — Risks
- Beta of 1.49 implies above-market volatility.
- Rich valuation (P/E 55.95×) increases downside if growth slows.
CGNX — Summary
Cognex Corporation (CGNX) is a mid-cap Technology company focused on Scientific & Technical Instruments, listed on NMS. Last price $58.19 with market cap $9.79B. Trailing P/E 55.95×. Revenue grew 16.9% year-over-year per public data. Notable strengths include revenue growth of 16.9% year-over-year. Key watch items include elevated trailing p/e (55.95×) limits valuation margin of safety. Public estimates and earnings snapshots for Cognex Corporation are on this site; ownership, live news, and deeper models remain in Vest Terminal.
Start Free — open CGNX in Vest Terminal
Access live data, filings, ownership, and analysis for Cognex Corporation.
Cognex Corporation FAQ
What does Cognex Corporation (CGNX) do?
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks in the United States, Europe, Greater China, and internationally. Its machine vision products are used to automate the manufacture and…
What is CGNX's P/E ratio?
Cognex Corporation has a trailing P/E of 55.95× based on publicly available market data.
Does CGNX pay a dividend?
Indicated dividend yield: 0.6%. Confirm ex-dates and payout history in Vest Terminal.
What sector is CGNX in?
Cognex Corporation is classified in Technology (Scientific & Technical Instruments) on NMS.
What is CGNX's market capitalization?
Approximate market cap: $9.79B.
What are the main risks for CGNX?
Key risks include above-average volatility (beta 1.49), elevated valuation, among factors on this page.
What are the strengths of CGNX?
Potential positives include revenue growth of 16.9% year-over-year, earnings growth of 79.2% year-over-year.
Where can I get analyst estimates for CGNX?
Public analyst price targets and consensus for Cognex Corporation are on the free /stocks/cgnx/estimates page. Deeper estimate history and models are available in Vest Terminal.